In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant <i>Enterococcus faecium</i>

Therapeutic options for infections caused by vancomycin-resistant enterococci are currently suboptimal. Combination regimens where fosfomycin is used alongside existing treatments are emerging given the proven synergistic potential and PK/PD properties. In the studies presented here, we tested five...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cristina Lagatolla, Jai W. Mehat, Roberto Marcello La Ragione, Roberto Luzzati, Stefano Di Bella
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-09-01
Col·lecció:	Antibiotics
Matèries:	vancomycin-resistant enterococci <i>Enterococcus faecium</i> synergy synergism oritavancin fosfomycin
Accés en línia:	https://www.mdpi.com/2079-6382/11/10/1334
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!